A detailed history of Mascoma Wealth Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mascoma Wealth Management LLC holds 638 shares of BMY stock, worth $37,559. This represents 0.01% of its overall portfolio holdings.

Number of Shares
638
Previous 638 -0.0%
Holding current value
$37,559
Previous $26,000 26.92%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$40.25 - $52.99 $322 - $423
-8 Reduced 1.24%
638 $26,000
Q2 2023

Aug 09, 2023

SELL
$63.71 - $70.74 $24,910 - $27,659
-391 Reduced 37.7%
646 $41,000
Q4 2021

Jan 21, 2022

SELL
$53.63 - $62.52 $5,416 - $6,314
-101 Reduced 8.88%
1,037 $64,000
Q3 2021

Oct 06, 2021

BUY
$59.17 - $69.31 $67,335 - $78,874
1,138 New
1,138 $67,000
Q2 2021

Jul 06, 2021

SELL
$61.91 - $67.42 $101,160 - $110,164
-1,634 Closed
0 $0
Q1 2021

Apr 26, 2021

BUY
$59.34 - $66.74 $96,961 - $109,053
1,634 New
1,634 $103,000
Q3 2019

Nov 21, 2019

SELL
$42.77 - $50.71 $73,393 - $87,018
-1,716 Closed
0 $0
Q1 2019

Apr 23, 2019

SELL
$45.12 - $53.8 $2,707 - $3,228
-60 Reduced 3.38%
1,716 $82,000
Q2 2018

Aug 13, 2018

BUY
$50.53 - $62.98 $9,095 - $11,336
180 Added 11.28%
1,776 $98,000
Q1 2018

Apr 24, 2018

SELL
$59.92 - $68.98 $8,988 - $10,347
-150 Reduced 8.59%
1,596 $101,000
Q4 2017

Feb 05, 2018

SELL
$59.94 - $65.35 $29,370 - $32,021
-490 Reduced 21.91%
1,746 $111,000
Q3 2017

Nov 07, 2017

BUY
$55.23 - $63.74 $123,494 - $142,522
2,236
2,236 $143,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Mascoma Wealth Management LLC Portfolio

Follow Mascoma Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mascoma Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mascoma Wealth Management LLC with notifications on news.